Abstract
At the beginning of the XXI century, 43 years after the description of the first solid-phase synthesis of a tetrapeptide by Bruce Merrifield, the synthesis of a tetrapeptide may still represent a synthetic challenge. This is the case of serratamolide, a cyclic tetradepsipeptide originally found in a culture of Serratia marcescens, which exhibits interesting properties as a chemotherapeutic agent. Here we explore several methodologies for the synthesis of serratamolide in order to find a strategy that allows its preparation for further biological studies.
Similar content being viewed by others
Abbreviations
- ACH:
-
α-cyano-4-hydroxy-cinnamic acid
- AM:
-
p-(R,S)-α-{1-[(9-fluorenyl)methoxyformamido]-2,4-dimethoxybenzyl}phenoxyacetic acid
- AcOEt:
-
ethyl acetate
- AcOH:
-
acetic acid
- BuLi:
-
n-butyl lithium
- 2-ClTrt:
-
2-chlorotrityl resin
- Da:
-
Dalton
- DCM:
-
dichloromethane
- β-DEX:
-
β-dextrane
- DIA:
-
diisopropylamine
- DIEA:
-
diisopropylethylamine
- DIPCDI:
-
N,N′-diisopropylcarbodiimide
- DMAP:
-
4-dimethylaminopyridine
- DMF:
-
N,N-dimethylformamide
- EDC:
-
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
- ESI-MS:
-
electrospray ionization-mass spectrometry
- Fmoc:
-
9-fluorenylmethoxycarbonyl
- Fmoc-l-Ser(tBu)-OH:
-
N-α-(9-fluorenylmethoxycarbonyl)-O-t-butyl-l-serine
- GC–MS:
-
gas chromatography–mass spectrometry
- β-HA:
-
β-hydroxydecanoic acid
- HATU:
-
1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo-[4,5-b]pyridinium hexafluorophosphate 3-oxide
- HMPA:
-
hexamethylphosphoramide
- 1H-NMR:
-
nuclear magnetic resonance of proton
- HOAt:
-
7-aza-1-hydroxybenzotriazole
- HOBt:
-
1-hydroxybenzotriazole
- HPLC:
-
high-performance liquid chromatography
- HPLC–MS:
-
high-performance liquid chromatography–mass spectrometry
- M :
-
molecular weight
- MALDI:
-
matrix-assisted laser desorption ionization
- MALDI-TOF:
-
matrix-assisted laser desorption ionization-time-of-flight
- MeCN:
-
acetonitrile
- MeOH:
-
methanol
- NMP:
-
N-methylpyrrolidone
- NMR:
-
nuclear magnetic resonance
- PyAOP:
-
(7-azabenzotriazol-1-yl-oxy)tripyrrolidinophosphonium hexafluorophosphate
- PyBOP:
-
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate
- Rf:
-
retention factor
- RP-HPLC:
-
reverse phase-high performance liquid chromatography
- tBu:
-
tert-butyl
- TFA:
-
trifluoroacetic acid
- THF:
-
tetrahydrofurane
- TIS:
-
triisopropylsilane
- TLC:
-
thin layer chromatography
- t r :
-
retention time
References
Albericio F., Cases M., Alsina J., Triolo S. A., Carpino L. A., Kates S. A. (1997) Tetrahedron Lett. 38:4853–4856
Atherton E., Sheppard R. (1989). Solid Phase Synthesis. A Practical Approach. IRL Press, Oxford
Barlos K., Chatzi O., Gatos D., Stavaropoulos G. (1991) Int. J. Peptide Protein Res. 37:513–520
Cartwright N. (1957) Biochem. J. 67:663–669
Escobar-Díaz, E., López-Martín, E. M., Hernández del Cerro, M., Puig-Kroger, A., Soto-Cerrato, V., Montaner, B., Giralt, E., García-Marco, J. A., Pérez-Tomás, R. and Garcia-Prado, A.: 2005, Leukemia, 1–8
Ganesan A. (2003) Methods Enzymol. 369 (Combinatorial Chemistry, part B):415–434
Goodman M., Levine L. (1964) J. Am. Chem. Soc. 86:2918
Iwata, T., Iwamoto, O. and Sugiyama, H.: 1990, Patent EP 0357 428 A1
Kaiser E., Colescott R. L., Bossiger C. D., Cook P. I. (1970) Anal. Biochem. 34:595–598
Kawai Y., Yano I., Kaneda K. (1998) Eur. J. Biochem. 171:73–80
Lloyd-Williams P., Albericio F., Giralt E. (1993) Tetrahedron 49:11065–11133
Matsuyama T., Murakami T., Fujita S., Yano I. (1986) J. Gen. Microbiol. 132:865–875
McKenzie A., Widdows S. (1915) J. Chem. Soc. 107:702–715
Overkleef H. S., Bos P. R., Hekking B., Gordon E., Ploegh H., Kessler B. (2000) Tetrahedron Lett. 41:6005–6009
Pérez-Tomás, R., Montaner-Ramoneda, B., Giralt-Lledó, E., Martinell-Pedemonte, M. and Vilaseca-Casas, M.: 2004, Patent WO 2004/031130
Senten K., Daniëls L., Van der Veken P., De Meester I., Lambeir A.-M., Scharpé S., Haemers A., Augustyns K. (2003) J. Comb. Chem. 5:336–344
Sheehan J., Ledis L. (1973) J. Am. Chem. Soc. 95:875–879
Shemyakin M., Ivanov V., Schelokov V., Shkrob A. (1964) Tetrahedron Lett. 1:47–54
Soto-Cerrato V., Montaner B., Martinell M., Vilaseca M., Giralt E., Pérez-Tomás R. (2005) Biochem. Pharmacol. 71:32–41
Wang Z., Zhao C., Pierce M., Fortunak J. (1999) Tetrahedron Asymmetry 10:225–228
Wasserman H., Keggi J., McKeon J. (1961) J. Am. Chem. Soc. 83:4107–4018
Wasserman H., Keggi J., McKeon J. (1962) J. Am. Chem. Soc. 84:2978–2982
Acknowledgments
The authors thank Nadine Payrot and Vanya Uzunova for their excellent technical assistance. This work was supported by the Generalitat de Catalunya (CeRBa and Grups Consolidats (2005SGR-00663)), Ministerio de Ciencia y Tecnología (BIO 2005-00295) and Cancer Research Technology Ltd.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teixidó, M., Caba, J.M., Prades, R. et al. Does the Solid-Phase Synthesis of a Tetrapeptide Represent a Challenge at the Onset of the XXI Century? The Case of Cyclo [(3R)-3-hydroxydecanoyl-l-seryl-(3R)-3-hydroxydecanoyl-l-seryl]. Int J Pept Res Ther 13, 313–327 (2007). https://doi.org/10.1007/s10989-007-9086-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-007-9086-z